The Goldman Sachs Group (NYSE:GS)- Vigorous Gainers/Losers Roundup: Halcon Resources (NYSE:HK)

The Goldman Sachs Group, Inc. (NYSE:GS) [Trend Analysis] luring active investment momentum, shares an advance 0.48% to $242.72. The market value of Goldman Sachs soared by $4 billion last Friday as President Trump signed an order to begin the process of dismantling Dodd-Frank, with former Goldman president Gary Cohn standing behind him.Cohn just walked away from Goldman Sachs with $285 million to become Trump’s top economic adviser.

Lately he has also become the face of the White House’s financial deregulation push, giving interviews on television and in newspapers. Goldman’s (GS) stock price has skyrocketed 33% since the election as Wall Street cheers the regulation-busting and promises of tax cuts. It also can’t hurt that Trump has appointed a handful of Goldman alumni to powerful positions in his administration. The total volume of 3.07 Million shares held in the session was surprisingly higher than its average volume of 4427.10 shares. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at 34.20%, and looking further price to next year’s EPS is 13.80%. While take a short look on price to sales ratio, that was 2.54 and price to earnings ratio of 14.83 attracting passive investors.

Several matter pinch shares of Halcon Resources Corporation (NYSE:HK) [Trend Analysis], as shares moving up 0.76% to $9.32 with a share volume of 1.12 Million. Halcón Resources Corporation (HK) reported that it has priced $850 million in aggregate principal amount of senior unsecured notes due 2025 in a private offering. The Notes will bear interest at a rate of 6.75% per annum and will be issued at par. The Notes offering was surged from the previously reported $700 million aggregate principal amount.

Halcón intends to use the net proceeds from the offering to repurchase and/or redeem the Company’s $700 million of currently outstanding 8.625% second lien notes due 2020, with the remaining net proceeds used to repay borrowings under the Company’s senior revolving credit facility. The stock is going forward its 52-week low with 4136.36% and moving down from its 52-week high price with -22.40%. To have technical analysis views, liquidity ratio of a company was calculated 1.20 as evaluated with its debt to equity ratio of 0.00. The float short ratio was 6.30%, as compared to sentiment indicator; Short Ratio was 4.56.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *